Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Predictive Oncology Inc (POAI)

Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Predictive Oncology Inc. Advances Strategic Alternatives Evaluation to Maximize Shareholder Value Quiver Quantitative, Inc. - Tue Dec 3, 4:16PM CST

Predictive Oncology Inc. evaluates strategic alternatives, including potential sales and partnerships, to enhance shareholder value.Quiver AI SummaryPredictive Oncology Inc. has announced advancements...

POAI : 0.8590 (+15.15%)
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives GlobeNewswire - Tue Dec 3, 6:00AM CST

POAI : 0.8590 (+15.15%)
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update GlobeNewswire - Wed Nov 13, 6:00AM CST

POAI : 0.8590 (+15.15%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs FinancialNewsMedia - Thu Jun 22, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END

ONCY : 1.0009 (+3.19%)
ONC.TO : 1.41 (+9.30%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 0.8590 (+15.15%)
MRTX : 58.70 (-0.17%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs PR Newswire - Thu Jun 22, 2023

/PRNewswire/ -- Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other...

ONC.TO : 1.41 (+9.30%)
ONCY : 1.0009 (+3.19%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 0.8590 (+15.15%)
MRTX : 58.70 (-0.17%)
Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm Globe Newswire - Tue Jul 26, 2022

EAGAN, Minn., July 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced a strategic move to further strengthen its business...

POAI : 0.8590 (+15.15%)
Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings Globe Newswire - Wed May 18, 2022

EAGAN, Minn., May 18, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven...

POAI : 0.8590 (+15.15%)
Predictive Oncology Announces $7.2 Million Registered Direct Offerings Globe Newswire - Mon May 16, 2022

EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven...

POAI : 0.8590 (+15.15%)
Predictive Oncology Reports First Quarter Financial Results Globe Newswire - Thu May 12, 2022

EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the...

POAI : 0.8590 (+15.15%)
Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology Globe Newswire - Tue Apr 26, 2022

EAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced that Theresa Ferguson has been named Senior Director...

POAI : 0.8590 (+15.15%)

Barchart Exclusives

Bearish on the Market? 2 Defensive Stocks for Maximum Portfolio Protection. Barchart - 1 hour ago
As economic growth is anticipated to slow, UBS highlights these two dividend-paying defensive stocks as smart picks, shifting focus away from cyclical stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot